New Tool for Estimating People’s Total Exposure to Potentially Harmful Chemicals Is Developed

A novel metric that estimates our “burden,” or cumulative exposure, to a family of thousands of synthetic chemicals that we encounter in everyday life with potentially adverse health impacts, has been created by a team of researchers at Mount Sinai.

Study Finds Persistent Disparities in Access to Prenatal Care Among Pregnant People Based on Citizenship Status and Education Level

Findings suggest exclusions to Medicaid because of immigration status may increase risk for maternal health care disparities in some immigrant populations

Mount Sinai’s Arnhold Institute for Global Health Announces Partnership With the Kathmandu University School of Medical Sciences and Dhulikhel Hospital in Nepal to Address Global Health

Agreement provides framework to enhance global health care, education, and research

Stem Cell Study Reveals How Neurons From PTSD Patients React to Stress

Stem cell-derived neurons from combat veterans with post-traumatic stress disorder (PTSD) react differently to a stress hormone than those from veterans without PTSD, a finding that could provide insights into how genetics can make someone more susceptible to developing PTSD following trauma exposure.

Brain’s Sensitivity to Different Types of Regret May Impact Mood Disorders Like Depression, Mount Sinai Researchers Find

Researchers from the Icahn School of Medicine at Mount Sinai have learned that the way the brain processes the complex emotion of regret may be linked to an individual’s ability to cope with stress, and altered in psychiatric disorders like depression.

Valentin Fuster, MD, PhD, Named President of Mount Sinai Heart

Mount Sinai Health System’s globally acclaimed cardiologist Valentin Fuster, MD, PhD, has been named President of Mount Sinai Heart, a newly created position, effective Sunday, January 1, 2023. Dr. Fuster will continue in his roles as Physician-in-Chief of The Mount Sinai Hospital and as the Richard Gorlin, MD/Heart Research Foundation Professor at the Icahn School of Medicine at Mount Sinai.

Human Cocaine and Heroin Addiction Is Found Tied to Impairments in Specific Brain Circuit Initially Implicated in Animals

Study results suggest the pre-frontal cortex-habenula circuit is potentially amenable for targeted interventions and prevention.

Mount Sinai Study Uncovers Mechanisms of Reactive Oxygen Species in Stem Cell Function and Inflammation Prevention

Mount Sinai researchers have published one of the first studies to demonstrate the importance of reactive oxygen species in maintaining stem cell function and preventing inflammation during wound repair, which could provide greater insights into the prevention and treatment of inflammatory bowel diseases (IBD), according to findings published in the journal Gut on October 3.

A Consistent Lack of Sleep Negatively Impacts Immune Stem Cells, Increasing Risk of Inflammatory Disorders and Heart Disease

Mount Sinai study also shows catching up on sleep doesn’t reverse possible negative effects on cellular level

Mount Sinai Researchers Use Artificial Intelligence to Uncover the Cellular Origins of Alzheimer’s Disease and Other Cognitive Disorders

Deep learning models represent “an entirely new paradigm for studying dementia”

Valentin Fuster, MD, PhD, Receives Prestigious Award from Cardiovascular Research Foundation

Mount Sinai Heart leader will be recognized for his exceptional career achievements at the 34th annual conference.

New Risk Score Predicts Mortality for Atrial Fibrillation Patients Undergoing Transcatheter Aortic Valve Replacement

Mount Sinai researchers develop new risk stratification tool to optimize patient care and outcomes after TAVR

“Polypill” Reduces Cardiovascular Mortality by 33 Percent in Patients Treated After a Heart Attack

A three-drug medication known as a “polypill,” developed by the Spanish National Center for Cardiovascular Research (CNIC) and Ferrer, is effective in preventing secondary adverse cardiovascular events in people who have previously had a heart attack, reducing cardiovascular mortality by 33 percent in this patient population.

Mount Sinai Launches Large-Scale Genetic Sequencing Project with the Regeneron Genetics Center

Mount Sinai Health System and the Icahn School of Medicine at Mount Sinai have launched a new human genome sequencing research project called the Mount Sinai Million Health Discoveries Program with the Regeneron Genetics Center (RGC), part of the industry-leading, New York-based biotechnology company Regeneron.

Prompt Recognition and Treatment Found Effective for Lung Disease in Patients Who Received New Drug for Advanced Cancer

Lung disease caused by a new drug for cancers—including metastatic or advanced breast cancer—can be effectively treated using approaches that focus on early detection and prompt management, according to a study published in ESMO Open on August 11, 2022.

Mount Sinai Announces the Formation of CastleVax Inc., a Clinical-Stage Infectious Diseases Company Developing Novel Vaccines and Therapeutics, Targeting Pandemic Threats and Diseases of Unmet Medical Need

The Mount Sinai Health System has launched CastleVax, Inc. (“CastleVax”), a clinical-stage vaccine research and development company.

High-Tech Imaging Offers New Way to Detect Signs of Early Glaucoma

Mount Sinai study shows flavoprotein fluorescence could serve as new biomarker

Black Patients Found Six Times More Likely to Have Advanced Vision Loss After Glaucoma Diagnosis Than White Patients

Black patients have a dramatically higher risk of advanced vision loss after a new diagnosis of primary open angle glaucoma (POAG) when compared to white patients, according to a new study from New York Eye and Ear Infirmary of Mount Sinai (NYEE).

High Blood Viscosity Can Predict Higher Risk of Death in Hospitalized COVID-19 Patients

EMBARGOED UNTIL JULY 18, 2022, 2PM EST                  Study Title: “Association of Blood Viscosity with Mortality among Patients Hospitalized with COVID-19” Journal: Journal of the American College of Cardiology – *Embargoed until July…

Mount Sinai Receives Prestigious Honor From American Hospital Association for Advancing Diversity, Inclusion, and Equity in Patient Care

Mount Sinai Health System named winner of 2022 Carolyn Boone Lewis Equity of Care Award

Blinding Eye Disease Is Strongly Associated With Heart Disease and Stroke

Patients with a specific form of age-related macular degeneration (AMD), a leading cause of blindness in the United States, are at significant risk for cardiovascular disease and stroke, according to new research from New York Eye and Ear Infirmary of Mount Sinai.

Stress Testing Can Help Determine Which Patients Are Likely to Benefit From Heart Procedures to Improve Survival

Mount Sinai study can help guide proper treatment course for patients depending on heart function and severity of heart damage

Blacks Found Twice as Likely to Have Atherosclerosis as Hispanics in Young Adult Populations in Underserved Communities

A unique Mount Sinai study focused on a multi-ethnic, underserved community in New York City shows that young Black adults are twice as likely to have atherosclerosis as similarly situated young Hispanic adults.

Immune Molecules From a Llama Could Provide Protection Against a Vast Array of SARS-like Viruses Including COVID-19, Researchers Say

Mount Sinai-led researchers have shown that tiny, robust immune particles derived from the blood of a llama could provide strong protection against every COVID-19 variant, including Omicron, and 18 similar viruses.

Study Finds Untreated Sleep Apnea May Increase Risk for Neurodegenerative Disease, PAP Therapies Crucial in Treating the Sleep Condition

Mount Sinai researchers have conducted one of the first studies to show the acute effect of obstructive sleep apnea on Alzheimer’s disease biomarkers, and the ability to even measure Alzheimer’s disease biomarkers from blood.

Specific Environmental Exposures may Help Predict Increased Risk of Death from Cardiovascular Disease

A new study from the Icahn School of Medicine at Mount Sinai quantifies the cardiovascular risk posed by exposure to specific environmental factors, showing, for example, that air pollution heightens the risk of heart disease mortality by 17 percent.

Mount Sinai Researchers Develop Machine Learning Model that Can Detect and Predict COVID-19 from Collected Data on Wearable Devices

Mount Sinai researchers have developed a machine learning algorithm that can determine if an individual has SARS-CoV-2 infections, the virus that causes COVID-19—with a high sensitivity and specificity—from the data collected by wearable devices.

Mount Sinai Researcher Receives Prestigious Award From the American Association of Indian Scientists in Cancer Research

Nina Bhardwaj, MD, PhD, Director of Immunotherapy at The Tisch Cancer Institute at Mount Sinai, has received the 2022 Lifetime Achievement in Cancer Research award from the American Association of Indian Scientists in Cancer Research (AAISCR).

Heart Failure Patients Unvaccinated Against COVID-19 Are Three Times More Likely to Die From It Than Boosted Heart Failure Patients

EMBARGOED UNTIL JUNE 9, 2022, 10AM EST (New York, NY – June 9, 2022) – Heart failure patients who are unvaccinated against SARS-CoV-2, the virus that causes COVID-19, are three times more likely to die if infected with the virus…

The Mount Sinai Hospital Recognized on Newsweek’s “America’s Best Maternity Hospitals 2022” List

The Mount Sinai Hospital has earned top honors on Newsweek’s list of “America’s Best Maternity Hospitals 2022” for providing high-quality maternity care from pregnancy through birth, as well as postpartum care to ensure the long-term health of both newborns and new mothers.

Mount Sinai Receives Landmark Gift from Royalty Pharma to Advance Health Equity

Marking a major advance in its efforts to achieve equity in the delivery of health care, the Icahn School of Medicine at Mount Sinai (Icahn Mount Sinai) announced today that its Institute for Health Equity Research (IHER) has received a landmark $20 million gift over five years from Royalty Pharma plc (Nasdaq: RPRX) and certain members of its management team.

Mount Sinai’s Brendan Carr, MD, MS, Receives Prestigious “Chair of the Year Award” from Emergency Medicine Residents’ Association

The Emergency Medicine Residents’ Association (EMRA) of the American College of Emergency Physicians has honored Brendan G. Carr, MD, MS, Chair of Emergency Medicine at the Icahn School of Medicine of Mount Sinai and Mount Sinai Health System, with the prestigious “2022 Chair of the Year Award.” He is the only department chair in the country to receive this distinction for 2022, recognizing his exceptional leadership.

Mount Sinai Cardiologist Develops New Risk Score to Help Predict Possible Contrast-Associated Kidney Injury After Percutaneous Coronary Intervention

Assessment can help stratify high-risk patients for monitoring before, during, and after procedures to improve outcomes

Novel Surgical Device Can Potentially Improve Outcomes of Coronary Bypass Grafting That Uses Leg Veins

(New York, NY – November 13, 2021) –A novel device called venous external support (VEST) may lead to increased longevity and durability of saphenous (leg) vein grafting during coronary artery bypass surgery, according to a new trial done in collaboration…

AMERICAN SOCIETY OF NEPHROLOGY ANNOUNCES THE BARBARA T. MURPHY ENDOWED LECTURESHIP

Today, the American Society of Nephrology (ASN) announced the Barbara T. Murphy Endowed Lectureship. Established by Verici Dx (LSE: VRCI), Renalytix (LSE RENX and Nasdaq RNLX), and the American Society of Transplantation (ATS), the new lectureship will honor Dr. Murphy’s legacy as a leader in transplant immunology and medicine by recognizing advances in kidney transplantation.

New Treatment Approach for Advanced Coronary Artery Disease Leads to Improved Outcomes

Study outlines better way to identify where stents are necessary

Renowned Physician-Scientist with Expertise in High-Risk Pregnancies Named System Chair of Obstetrics, Gynecology, and Reproductive Science at Mount Sinai Health System

Joanne L. Stone, MD, a leading physician-scientist in women’s health with special expertise in fetal imaging and caring for high-risk pregnancies, has been named the Chair of Obstetrics, Gynecology, and Reproductive Science for the Icahn School of Medicine at Mount Sinai and the Mount Sinai Health System. Dr. Stone currently serves as Director of the Maternal-Fetal Medicine and Fellowship program for the Mount Sinai Health System, Vice Chair for Diversity and Inclusion of the OB/GYN Department, and Immediate Past President of the Faculty Council.

Shrinking Waveforms on Electrocardiograms Predict Worsening Health and Death of Hospitalized COVID-19 and Influenza Patients

Spotting changes in the heart’s electrical activity may prompt more-aggressive treatment and monitoring.

Mount Sinai Neurobiologist Selected as a Howard Hughes Medical Institute Investigator

The Howard Hughes Medical Institute (HHMI) has selected Ian Maze, PhD, Associate Professor of Neuroscience, and Pharmacological Sciences, at the Icahn School of Medicine at Mount Sinai, as an HHMI Investigator.

Mount Sinai Researchers Use Wearable Devices to Identify Psychological Effects of Pandemic

Study links changes in heart rate variability with degree of resilience, as part of larger effort to understand and mitigate the effects of COVID-19 on health care workers